<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31712448</article-id>
<article-id pub-id-type="pmc">6883834</article-id>
<article-id pub-id-type="publisher-id">201909452</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1909452116</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Developmental Biology</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Hepatocyte nuclear factor-1β regulates Wnt signaling through genome-wide competition with β-catenin/lymphoid enhancer binding factor</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chan</surname>
<given-names>Siu Chiu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pontoglio</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-8698-1185</contrib-id>
<name>
<surname>Igarashi</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Medicine, <institution>University of Minnesota</institution>, Minneapolis, <addr-line>MN</addr-line> 55455;</aff>
<aff id="aff2"><sup>b</sup>Minnesota Supercomputing Institute, <institution>University of Minnesota</institution>, Minneapolis, <addr-line>MN</addr-line> 55455;</aff>
<aff id="aff3"><sup>c</sup>Department of Development, Reproduction and Cancer, Institut Cochin, Institut National de la Santé et de la Recherche Médicale U1016/Centre National de la Recherche Scientifique Unité Mixte de Recherche 8104, <institution>Université Paris-Descartes</institution>, Paris, <country>France</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence may be addressed. Email: <email>igarashi@umn.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Janet Rossant, Hospital for Sick Children, University of Toronto, Toronto, Canada, and approved October 18, 2019 (received for review June 3, 2019)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: S.C.C. and P.I. designed research; M.P. contributed new reagents/analytic tools; S.C.C., Y.Z., and P.I. analyzed data; and S.C.C., Y.Z., and P.I. wrote the paper.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no competing interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>26</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>116</volume>
<issue>48</issue>
<fpage>24133</fpage>
<lpage>24142</lpage>
<permissions>
<copyright-year>2019</copyright-year>
<license>
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://www.pnas.org/site/aboutpnas/licenses.xhtml</ali:license_ref>
<license-p>Published under the <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/site/aboutpnas/licenses.xhtml">PNAS license</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201909452.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Canonical Wnt signaling plays essential roles in cell proliferation, differentiation, and survival. Binding of Wnt ligands to their receptors results in translocation of β-catenin to the nucleus, where it interacts with TCF/LEF transcription factors and activates Wnt target genes. Here, we show that the transcription factor HNF-1β competes with the binding of β-catenin/LEF complexes to DNA. We identify a composite DNA element to which HNF-1β binds and thereby inhibits β-catenin-dependent transcription. Genome-wide chromatin immunoprecipitation sequencing strikingly revealed that 50% of β-catenin-occupied sites in HNF-1β mutant cells colocalized with HNF-1β-occupied sites in wild-type cells, indicating that reciprocal binding is widespread. These studies reveal a direct transcriptional mechanism for inhibition of canonical Wnt signaling.</p>
</abstract>
<abstract>
<p>Hepatocyte nuclear factor-1β (HNF-1β) is a tissue-specific transcription factor that is essential for normal kidney development and renal tubular function. Mutations of HNF-1β produce cystic kidney disease, a phenotype associated with deregulation of canonical (β-catenin–dependent) Wnt signaling. Here, we show that ablation of HNF-1β in mIMCD3 renal epithelial cells produces hyperresponsiveness to Wnt ligands and increases expression of Wnt target genes, including <italic>Axin2</italic>, <italic>Ccdc80</italic>, and <italic>Rnf43</italic>. Levels of β-catenin and expression of Wnt target genes are also increased in HNF-1β mutant mouse kidneys. Genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) in wild-type and mutant cells showed that ablation of HNF-1β increases by 6-fold the number of sites on chromatin that are occupied by β-catenin. Remarkably, 50% of the sites that are occupied by β-catenin in HNF-1β mutant cells colocalize with HNF-1β–occupied sites in wild-type cells, indicating widespread reciprocal binding. We found that the Wnt target genes <italic>Ccdc80</italic> and <italic>Rnf43</italic> contain a composite DNA element comprising a β-catenin/lymphoid enhancer binding factor (LEF) site overlapping with an HNF-1β half-site. HNF-1β and β-catenin/LEF compete for binding to this element, and thereby HNF-1β inhibits β-catenin–dependent transcription. Collectively, these studies reveal a mechanism whereby a transcription factor constrains canonical Wnt signaling through direct inhibition of β-catenin/LEF chromatin binding.</p>
</abstract>
<kwd-group>
<kwd>Wnt</kwd>
<kwd>transcription</kwd>
<kwd>polycystic kidney disease</kwd>
<kwd>kidney development</kwd>
<kwd>β-catenin</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<named-content content-type="funder-id">100000062</named-content></funding-source>
<award-id rid="sp1">R37DK042921</award-id>
<principal-award-recipient>Peter Igarashi</principal-award-recipient>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>